HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Schistosomiasis does not contribute to death or recurrence of nontyphoid Salmonella bacteremia in human immunodeficiency virus-infected Malawian adults.

Abstract
Nontyphoid Salmonella (NTS) bacteremia has a very high mortality and recurrence rate among human immunodeficiency virus (HIV)-infected Malawian adults. Concurrent schistosomal infection might cause persistence of NTS infection and poor response to antibiotic therapy. Therefore, we tested serum samples for Schistosoma-specific circulating anodic antigen to diagnose coinfection with schistosomiasis among consecutive HIV-positive adults with NTS bacteremia. The results suggest that active schistosomiasis is not associated with adverse outcome of NTS bacteremia in this population, in contrast to other groups.
AuthorsMelita A Gordon, Eduard E Zijlstra, Cynthia W A Naus, Leo G Visser, Malcolm E Molyneux, Lisette van Lieshout
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 37 Issue 12 Pg. e177-9 (Dec 15 2003) ISSN: 1537-6591 [Electronic] United States
PMID14689364 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Helminth
  • Glycoproteins
  • Helminth Proteins
  • circulating anodic antigen, Schistosoma mansoni
Topics
  • Adult
  • Animals
  • Antigens, Helminth (blood)
  • Bacteremia (complications, mortality)
  • Female
  • Glycoproteins (blood)
  • HIV
  • HIV Infections (complications, mortality)
  • Helminth Proteins (blood)
  • Humans
  • Male
  • Salmonella Infections (complications, mortality)
  • Schistosomiasis (complications, mortality)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: